Biofil Accounts Payable vs Cash And Short Term Investments Analysis

BIOFILCHEM   49.34  1.63  3.20%   
Biofil Chemicals financial indicator trend analysis is way more than just evaluating Biofil Chemicals Pha prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biofil Chemicals Pha is a good investment. Please check the relationship between Biofil Chemicals Accounts Payable and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Accounts Payable vs Cash And Short Term Investments

Accounts Payable vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biofil Chemicals Pha Accounts Payable account and Cash And Short Term Investments. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Biofil Chemicals' Accounts Payable and Cash And Short Term Investments is 0.84. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Biofil Chemicals Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Biofil Chemicals' Accounts Payable and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Biofil Chemicals Pharmaceuticals are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Accounts Payable i.e., Biofil Chemicals' Accounts Payable and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.84
Relationship DirectionPositive 
Relationship StrengthStrong

Accounts Payable

An accounting item on the balance sheet that represents Biofil Chemicals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Biofil Chemicals Pha are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Biofil Chemicals Pha balance sheet. This account contains Biofil Chemicals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Biofil Chemicals Pharmaceuticals fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Biofil Chemicals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biofil Chemicals Pha current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofil Chemicals Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
The current year's Selling General Administrative is expected to grow to about 8.1 M. The current year's Tax Provision is expected to grow to about 2.4 M
 2022 2023 2024 2025 (projected)
Interest Expense425K415K373.5K354.8K
Depreciation And Amortization4.3M4.0M4.6M3.1M

Biofil Chemicals fundamental ratios Correlations

-0.340.71-0.37-0.3-0.59-0.770.58-0.27-0.26-0.17-0.650.04-0.17-0.320.99-0.25-0.5-0.13-0.19-0.32-0.93-0.040.03-0.26-0.35
-0.34-0.750.620.980.720.5-0.890.320.980.840.53-0.180.851.0-0.260.790.09-0.110.971.00.54-0.7-0.160.790.76
0.71-0.75-0.36-0.63-0.92-0.660.93-0.57-0.64-0.49-0.620.02-0.49-0.740.62-0.69-0.270.3-0.57-0.74-0.750.680.07-0.75-0.86
-0.370.62-0.360.630.430.63-0.47-0.020.60.530.66-0.620.530.6-0.350.460.290.110.60.60.48-0.11-0.440.570.38
-0.30.98-0.630.630.60.46-0.810.191.00.840.49-0.190.840.98-0.240.720.060.010.990.980.5-0.57-0.190.680.62
-0.590.72-0.920.430.60.59-0.870.620.60.460.56-0.140.460.71-0.490.670.26-0.280.550.710.68-0.69-0.140.770.95
-0.770.5-0.660.630.460.59-0.560.130.420.230.99-0.430.230.46-0.760.480.27-0.190.380.470.8-0.13-0.490.520.47
0.58-0.890.93-0.47-0.81-0.87-0.56-0.42-0.81-0.77-0.530.0-0.77-0.870.49-0.77-0.190.1-0.76-0.89-0.710.7-0.01-0.78-0.84
-0.270.32-0.57-0.020.190.620.13-0.420.220.00.09-0.10.00.34-0.190.290.14-0.290.180.320.22-0.56-0.010.540.63
-0.260.98-0.640.61.00.60.42-0.810.220.840.47-0.190.840.98-0.190.740.03-0.041.00.980.46-0.63-0.190.710.65
-0.170.84-0.490.530.840.460.23-0.770.00.840.270.021.00.83-0.090.640.010.240.850.850.43-0.50.140.580.51
-0.650.53-0.620.660.490.560.99-0.530.090.470.27-0.50.270.5-0.640.520.19-0.240.430.50.72-0.19-0.560.570.48
0.04-0.180.02-0.62-0.19-0.14-0.430.0-0.1-0.190.02-0.50.02-0.160.04-0.250.230.08-0.19-0.16-0.03-0.010.78-0.44-0.17
-0.170.85-0.490.530.840.460.23-0.770.00.841.00.270.020.83-0.090.640.010.240.850.850.43-0.50.140.580.51
-0.321.0-0.740.60.980.710.46-0.870.340.980.830.5-0.160.83-0.240.750.11-0.110.971.00.52-0.7-0.160.780.75
0.99-0.260.62-0.35-0.24-0.49-0.760.49-0.19-0.19-0.09-0.640.04-0.09-0.24-0.14-0.52-0.14-0.13-0.24-0.89-0.160.06-0.15-0.23
-0.250.79-0.690.460.720.670.48-0.770.290.740.640.52-0.250.640.75-0.14-0.28-0.20.720.790.39-0.7-0.230.80.74
-0.50.09-0.270.290.060.260.27-0.190.140.030.010.190.230.010.11-0.52-0.280.050.00.080.460.130.19-0.030.09
-0.13-0.110.30.110.01-0.28-0.190.1-0.29-0.040.24-0.240.080.24-0.11-0.14-0.20.05-0.01-0.10.190.540.38-0.27-0.42
-0.190.97-0.570.60.990.550.38-0.760.181.00.850.43-0.190.850.97-0.130.720.0-0.010.970.41-0.6-0.190.680.61
-0.321.0-0.740.60.980.710.47-0.890.320.980.850.5-0.160.851.0-0.240.790.08-0.10.970.53-0.7-0.140.790.76
-0.930.54-0.750.480.50.680.8-0.710.220.460.430.72-0.030.430.52-0.890.390.460.190.410.53-0.10.010.40.48
-0.04-0.70.68-0.11-0.57-0.69-0.130.7-0.56-0.63-0.5-0.19-0.01-0.5-0.7-0.16-0.70.130.54-0.6-0.7-0.10.05-0.79-0.86
0.03-0.160.07-0.44-0.19-0.14-0.49-0.01-0.01-0.190.14-0.560.780.14-0.160.06-0.230.190.38-0.19-0.140.010.05-0.33-0.16
-0.260.79-0.750.570.680.770.52-0.780.540.710.580.57-0.440.580.78-0.150.8-0.03-0.270.680.790.4-0.79-0.330.86
-0.350.76-0.860.380.620.950.47-0.840.630.650.510.48-0.170.510.75-0.230.740.09-0.420.610.760.48-0.86-0.160.86
Click cells to compare fundamentals

Biofil Chemicals Account Relationship Matchups

Biofil Chemicals fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets332.4M187.3M314.1M470.8M541.5M568.5M
Short Long Term Debt Total4.3M4.6M5.2M4.4M4.0M3.8M
Other Current Liab1.4M1.6M933K2.9M3.3M3.5M
Total Current Liabilities167.5M14.9M137.3M285.2M328.0M344.4M
Total Stockholder Equity161.3M168.4M173.0M182.0M209.3M119.5M
Property Plant And Equipment Net97.8M94.2M90.0M86.2M99.2M99.3M
Net Debt(107K)3.2M5.0M(18.4M)(16.6M)(15.8M)
Retained Earnings(337.7M)(330.6M)(128.5M)(316.9M)(364.5M)(382.7M)
Accounts Payable158.5M6.0M126.5M275.5M316.9M332.7M
Cash4.4M1.5M260K22.8M26.3M27.6M
Non Current Assets Total97.8M94.2M90.0M86.8M99.8M99.9M
Non Currrent Assets Other(37K)(191K)(307K)508K457.2K480.1K
Cash And Short Term Investments4.4M1.5M377K22.8M26.3M27.6M
Net Receivables186.0M71.8M205.0M330.3M379.8M398.8M
Liabilities And Stockholders Equity332.4M187.3M314.1M470.8M541.5M568.5M
Non Current Liabilities Total3.6M4.0M3.8M3.6M3.2M3.0M
Inventory43.4M12.9M12.1M25.5M29.3M30.8M
Other Current Assets793K7.0M6.5M5.5M6.3M5.4M
Total Liab171.1M18.9M141.0M288.8M332.1M348.7M
Total Current Assets234.6M93.1M224.1M384.1M441.7M463.8M
Short Term Debt4.3M4.6M2.9M4.4M4.0M3.8M
Current Deferred Revenue(4.3M)4.3M2.3M1.4M1.7M1.7M
Net Tangible Assets136.5M148.8M161.3M168.4M193.6M140.0M
Short Long Term Debt4.3M4.6M5.2M4.4M4.0M3.8M
Property Plant Equipment100.9M97.8M94.2M90.0M103.5M103.6M
Net Invested Capital165.6M173.0M178.2M186.4M214.4M182.9M
Cash And Equivalents2.6M4.4M1.4M260K234K222.3K
Net Working Capital67.1M78.2M86.8M98.8M113.7M71.0M
Property Plant And Equipment Gross115.5M116.2M116.3M116.5M134.0M127.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Biofil Stock

Balance Sheet is a snapshot of the financial position of Biofil Chemicals Pha at a specified time, usually calculated after every quarter, six months, or one year. Biofil Chemicals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biofil Chemicals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biofil currently owns. An asset can also be divided into two categories, current and non-current.